- Investing Ideas
- Global Pharmaceuticals & Biotech High Risk Large Caps
Global Pharmaceuticals & Biotech High Risk Large Caps
Results
6
Are you holding one of these? A list of some of the most volatile large-cap stocks over the past five years.
6 companies
Natera
Market Cap: US$27.9b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$190.31
7D
-3.5%
1Y
33.5%
BioNTech
Market Cap: US$21.8b
A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.
BNTX
US$90.10
7D
-11.6%
1Y
-7.6%
Illumina
Market Cap: US$18.6b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$115.56
7D
-9.9%
1Y
37.5%
Sam Chun Dang Pharm
Market Cap: ₩18.0t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩772,000.00
7D
1.0%
1Y
303.3%
Regencell Bioscience Holdings
Market Cap: US$11.7b
Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.
RGC
US$24.00
7D
-0.9%
1Y
6,372.7%
Elanco Animal Health
Market Cap: US$11.7b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$22.68
7D
-5.2%
1Y
120.0%